Skip to content
healthcare.dev

MIMRYLO

NDC 63020-745, rusfertide, kit, from Takeda Pharmaceuticals America, Inc..

Product NDC
63020-745
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
KIT
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA220605
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63020-745 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
63020-745-40630200745401 KIT in 1 CARTON (63020-745-40) * 41 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-740-40) * .6 mL in 1 SYRINGE (63020-600-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/101aff01-31ed-4841-a8b6-0a5a8503189b

Use it

Look up 63020-745 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63020-745 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63020-745. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.